Spot BioSystems is a bioengineering firm that specializes in extracellular vesicle mediated mRNA therapy
Spot Biosystems has raised $40.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Spot Biosystems's investors include IDG Capital, LDV Partners, StartX (Stanford-StartX Fund), Saltagen Ventures, Advantech Capital.
Spot Biosystems is headquartered in Palo Alto, United States.
Spot BioSystems is a bioengineering firm that specializes in extracellular vesicle mediated mRNA therapy
Spot Biosystems is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spot Biosystems — Funding & Investors." VCBacked, June 17, 2026, https://www.vcbacked.co/company/spot-biosystems. Accessed September 29, 2026.
VCBacked. (2026). Spot Biosystems — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/spot-biosystems
{{cite web |title=Spot Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/spot-biosystems |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated